Alpex Solar appoints Gaurav Bector as Global Head of EPC, leveraging his 30+ years of experience to drive global expansion.

Alpex Solar's standalone net profit jumped to Rs 29.05 crore in FY24, driven by higher revenue. The company's shares were listed on NSE Emerge in February 2024.

Nephro Care India Ltd files draft papers for an IPO on NSE Emerge, aiming to raise funds for a new multispecialty hospital in Kolkata. The IPO comprises a fresh issuance of 45.84 lakh equity shares.

Alpex Solar has secured a Rs 12 crore contract under the PM-KUSUM scheme to install 500 solar water pumps in Jharkhand. The project involves supply, installation, and commissioning of the pumps at...

Alpex Solar, a solar energy solutions provider, has fixed the price band for its Rs 75-crore IPO at Rs 109-115 per share. The issue opens on Feb 8 and closes on Feb 12.

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...

Ceigall India's Rs 1,253 crore IPO opens on August 1 with a price band of Rs 380-401 per share. The infrastructure company's issue includes fresh issuance and OFS. Learn more.

BHIVE Workspace leases 42,000 sq ft office space in Bengaluru from Brigade Group, expanding its presence in the city's key business hubs. The new facility will support 1200+ seats, reflecting the...

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...

RBI Governor highlights digitalisation's impact on banking, emphasizing next-generation services, affordable finance, and challenges like cybersecurity and data privacy.

Ceigall India's Rs 1,253 crore IPO opens on August 1 with a price band of Rs 380-401 per share. The infrastructure company's issue includes fresh issuance and OFS. Learn more.